⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of i2b2 tranSMART Foundation and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
i2b2 tranSMART Foundation
↗Boston, USA
The i2b2 tranSMART Foundation is a non-profit organization dedicated to advancing precision medicine through the development and support of open-source, cloud-based data-sharing and analysis platforms. It serves a global community of universities, disease foundations, pharmaceutical companies, and government agencies by providing tools that integrate, standardize, and analyze heterogeneous clinical and research data.
The foundation was formed through the 2017 merger of the i2b2 Foundation and the tranSMART Foundation. It maintains key open-source research platforms—i2b2 (Informatics for Integrating Biology and the Bedside), SHRINE, and tranSMART—which are used by hundreds of hospitals and research centers worldwide to accelerate translational research and clinical discovery.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Digital Health
Sub-Industry:Translational Research Informatics
SIZE & FINANCIALS
Employees:1-50
Founded:2013
Ownership:nonprofit
Status:operating
0
CORPORATE STRUCTURE
Key Partnerships:Harvard Medical School (Department of Biomedical Informatics), Dell Technologies, National Institutes of Health (NCATS), Various global academic medical centers and pharmaceutical companies
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Diane Keogh - Executive Director
Isaac Kohane - Board Chair
Board Members:Isaac Kohane, Elmer Bernstam, Susanne E. Churchill, David Dimond
LINKS
Website:transmartfoundation.org
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with i2b2 tranSMART Foundation. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.